Recommendations for the use of antithrombotics in children Newsletter Article 11 February 2013 Pages: 2 - 2
Lamivudine spares resources in HIV infection, reveals CAESAR study Carlene Todd Newsletter Article 11 February 2013 Pages: 3 - 4
Casemix funding and DRGs ignore quality and outcome issues Newsletter Article 11 February 2013 Pages: 5 - 5
New drugs - modest health benefits at considerable cost Newsletter Article 11 February 2013 Pages: 5 - 5
Imperfect HIV vaccines could still be cost effective Newsletter Article 11 February 2013 Pages: 6 - 6
Terbinafine superior to itraconazole in onychomycosis Newsletter Article 11 February 2013 Pages: 6 - 6
Pharmaceutical care programme in the US is worth its cost Newsletter Article 11 February 2013 Pages: 6 - 6
Impact of pharmacoeconomic guidelines on studies in Canada Newsletter Article 11 February 2013 Pages: 7 - 7
Prediction models can identify high-risk children with asthma Newsletter Article 11 February 2013 Pages: 7 - 7
Cost analysis of protease inhibitor therapy in HIV infection in Canada Newsletter Article 11 February 2013 Pages: 9 - 9
Protecting elderly people from inappropriate medications Newsletter Article 11 February 2013 Pages: 11 - 11
Risk-sharing linked to formulary listing in Canada Newsletter Article 11 February 2013 Pages: 12 - 12